HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

N-Acetyl-DL-cysteine → cobalt-dichloride-N-acetyl cysteine

HRID 80283
Print

Reaction equation

HRID 80283 reaction equation
O.O.O.O.O.O.[Co:7]([Cl:9])[Cl:8].[C:10]([NH:13][C@H:14]([C:17]([OH:19])=[O:18])[CH2:15][SH:16])(=[O:12])[CH3:11].SCC(C(O)=O)NC(C)=O>O>[C:10]([NH:13][C@H:14]([C:17]([OH:19])=[O:18])[CH2:15][SH:16])(=[O:12])[CH3:11].[Co:7]([Cl:9])[Cl:8]
ParticipantsProcedureSources & evidenceReaction notes

Participants

5

Reactant 3

HCID 581N-Acetyl-DL-cysteineHCID 12035N-Acetyl-L-CysteineHCID 517166Dichlorocobalt hexahydrate

Product 1

HCID 59051191cobalt-dichloride-N-acetyl cysteine

Reagents, catalysts & solvents 1

HCID 962WaterSolvent

Procedure

Cobalt chloride hexahydrate (CoCl2-6H2O (mw=237.9 g/mol, available from Acros)) and NAC (N-Acetyl-L-Cysteine, HSCH2CH(NHCOCH3)CO2H (mw=163.19 g/mol, available from Sigma)) was dissolved in water, resulting in the formation of cobalt-dichloride-N-acetyl cysteine (CoCl2—NAC), referred to herein as the Co—NAC contrast agent. All chemicals were purchased from commercial sources and were used without any further purification. For toxicity testing, two different Co—NAC solutions with low (1 wt. %) concentration of cobalt chloride and with high (10%) concentration were prepared. In both cases, the concentration of NAC in the solution was 2 wt. %. The Co—NAC solution with low cobalt chloride concentration was prepared by dissolving 100 mg (0.42 mmol) of CoCl2-6H2O and 200 mg (1.22 mmol) of NAC in 9.7 mL distillated water. The solution with high cobalt chloride concentration was prepared by dissolving 1000 mg (4.2 mmol) of CoCl2-6H2O and 200 mg (1.22 mmol) of NAC in 8.8 mL distilled water. In both cases, the solutions were sonicated at the room temperature for 15 minutes to completely dissolve the components. To avoid any contaminations and bacteria grow, the fresh Co—NAC solutions were prepared every morning for 6 days and immediately delivered for toxicity testing (see, Example 2 below).

Sources & evidence

ORD record
ord-0373193937734e92ab02d6b2cd28d852
Source dataset
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08846006B2

Reaction notes

On this pageParticipantsProcedureSources & evidenceReaction notes